MENU
Terns Pharmaceuticals (TERN) Ownership - Who owns Terns Pharmaceuticals?
Profile
Industry
N/A
Address
1065 East Hillsdale Boulevard
Phone
+1 650 525-5535
Employees
66
Web
https://www.ternspharma.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
525.68M
P/E Ratio
N/A
Total Cash
225.3M
Projected Growth
N/A
Total Debt
249K
Revenue
N/A
Risk (Beta)
-0.45
Dividend Yield
N/A
Total Cash/Share
3.20
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
TERN
Capitalization
526M
P/E Ratio
N/A
Risk (Beta)
-0.45
Dividend Yield
N/A
Total Cash
225M
Total Cash/Share
3.20
Total Debt
249K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
219M
P/B Ratio
2.40
Cash Flow
N/A
Earnings
-1.32
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
7K
Current Ratio
21.02
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-107.31M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-36.84
Shares Held By Institutions
508M
Shares Outstanding - Current
70.4M
Total Liabilities
12.2M
Total Volume MTD
N/A
Value
N/A
Gain YTD
15.100
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
1065 East Hillsdale Boulevard
Phone
+1 650 525-5535
Employees
66
Web
https://www.ternspharma.com